ArticleFrontiers in microbiology2018
Characterization and Genomic Study of Phage vB_EcoS-B2 Infecting Multidrug-Resistant
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Characterization of a novel phage-plasmid vB_EcoM_ED targeting multidrug-resistant Escherichia coli isolates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Isolation, Identification, Biological Characteristics, and In Vitro and In Vivo Antibacterial Effects of a Bovine-DerivedMicroorganisms · 2026Article
- A comprehensive analysis of the kinetics of infection of lytic bacteriophages specific to the ESKAPE and critical pathogens.World journal of microbiology & biotechnology · 2026Review
- Characterization and Antibacterial Potential ofIndian journal of microbiology · 2025Article
- Bacteriophage therapy for controlling poultry production problems.Iranian journal of veterinary research · 2025Review
- Biological characterization of novelFrontiers in microbiology · 2025Article
- A Novel Bacteriophage Infecting Multi-Drug- and Extended-Drug-ResistantAntibiotics (Basel, Switzerland) · 2024Article
- Diversity ofMicrobiology spectrum · 2024Article
- A lytic phage to control multidrug-resistant avian pathogenicFrontiers in cellular and infection microbiology · 2023Article
- Prophylactic Delivery of a Bacteriophage Cocktail in Feed Significantly Reduces Salmonella Colonization in Pigs.Microbiology spectrum · 2022Article
- Isolation and characterization of two homolog phages infectingFrontiers in microbiology · 2022Article
- Characterization of a New and Efficient Polyvalent Phage InfectingMicroorganisms · 2021Article
- Molecular Characteristics of Novel Phage vB_ShiP-A7 Infecting Multidrug-ResistantFrontiers in microbiology · 2021Article
- First Characterization of aFrontiers in microbiology · 2021Article
- Evaluation of Potential ARG Packaging by Two Environmental T7-Like Phage during Phage-Host Interaction.Viruses · 2020Article
- Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way?Antibiotics (Basel, Switzerland) · 2020Review
- Isolation and characterization of a novelJournal of environmental health science & engineering · 2020Article
- Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains ofMicrobial genomics · 2020Article
- Characterization of a Lytic Bacteriophage as an Antimicrobial Agent for Biocontrol of Shiga Toxin-ProducingAntibiotics (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential of bacteriophage as an alternative antibacterial agent has been reconsidered for control of pathogenic bacteria due to the widespread occurrence of multi-drug resistance bacteria. More and more lytic phages have been isolated recently. In the present study, we isolated a lytic phage named vB_EcoS-B2 from waste water. VB_EcoS-B2 has an icosahedral symmetry head and a long tail without a contractile sheath, indicating that it belongs to the family
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.